Patents by Inventor Dae-Gyu Kim

Dae-Gyu Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240136079
    Abstract: A method for producing a lead-free X-ray shielding material using bismuth iodide is provided, the method including a first step of producing porous PDMS (Polydimethylsiloxane); a second step of producing a mixed solution of BiI3 and THF; and a third step of immersing the porous PDMS into the mixed solution such that the BiI3 is loaded into the porous PDMS to produce a BiI3-PDMS composite material.
    Type: Application
    Filed: October 19, 2023
    Publication date: April 25, 2024
    Applicant: PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
    Inventors: Jung Hwan KIM, Seok Gyu KANG, Ha Yeong KANG, Dae Seong KWON
  • Patent number: 11949881
    Abstract: The present invention discloses an encoding apparatus using a Discrete Cosine Transform (DCT) scanning, which includes a mode selection means for selecting an optimal mode for intra prediction; an intra prediction means for performing intra prediction onto video inputted based on the mode selected in the mode selection means; a DCT and quantization means for performing DCT and quantization onto residual coefficients of a block outputted from the intra prediction means; and an entropy encoding means for performing entropy encoding onto DCT coefficients acquired from the DCT and quantization by using a scanning mode decided based on pixel similarity of the residual coefficients.
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: April 2, 2024
    Assignees: Electronics and Telecommunications Research Institute, Kwangwoon University Research Institute for Industry Cooperation, Industry-Academia Cooperation Group of Sejong University
    Inventors: Se-Yoon Jeong, Hae-Chul Choi, Jeong-Il Seo, Seung-Kwon Beack, In-Seon Jang, Jae-Gon Kim, Kyung-Ae Moon, Dae-Young Jang, Jin-Woo Hong, Jin-Woong Kim, Yung-Lyul Lee, Dong-Gyu Sim, Seoung-Jun Oh, Chang-Beom Ahn, Dae-Yeon Kim, Dong-Kyun Kim
  • Patent number: 11941839
    Abstract: Provided is a 10-20 system-based position information providing method performed by a computer. The method comprises the steps of: obtaining a head image of a subject; receiving, from a user, an input of at least four reference points on the basis of the head image; calculating central coordinates in the head image on the basis of the at least four reference points; and providing 10-20 system-based position information on the basis of the central coordinates.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: March 26, 2024
    Assignee: NEUROPHET Inc.
    Inventors: Dae Gyu Min, Jun Kil Been, Dong Hyeon Kim
  • Publication number: 20240099045
    Abstract: Provided are an electroluminescent device, a method of manufacturing the same, and a display device including the same, the electroluminescent device including a first electron auxiliary layer, a first light emitting layer, and a first electrode disposed on a first surface of a transparent electrode; and a second electron auxiliary layer, a second light emitting layer, and a second electrode disposed on a second surface of the transparent electrode, wherein the first electron auxiliary layer and the second electron auxiliary layer each include a plurality of zinc oxide nanoparticles, a ratio (t1/t0) of a thickness (t1) of the first electron auxiliary layer to a thickness (t0) of the transparent electrode and a ratio (t2/t0) of a thickness (t2) of the second electron auxiliary layer to the thickness (t0) of the transparent electrode are each in the range of about 0.1 to about 4.0.
    Type: Application
    Filed: September 13, 2023
    Publication date: March 21, 2024
    Inventors: Heejae LEE, Tae Ho KIM, Jun-Mo YOO, Ilyoung LEE, Shin Ae JUN, Dae Young CHUNG, Moon Gyu HAN
  • Publication number: 20240092060
    Abstract: Provided is an unconstrained vibration damping metal sheet with foam pores. The unconstrained vibration damping metal sheet of the present invention comprises: a metal sheet; an organic-inorganic pretreatment layer containing an acrylic resin formed on the metal sheet; and a foam resin layer formed on the pretreatment layer, the foam resin layer containing, based on weight % thereof, a thermoplastic polyvinyl chloride resin: 40-80%, a plasticizer: 5-40%, a foaming agent: 0.1-10%, an oxide-based crosslinker: 1-4%, and spherical silica: 1-10%.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 21, 2024
    Applicant: POSCO Co., Ltd
    Inventors: Jin-Tae Kim, Dae-Gyu Kang, Yang-Ho Choi, Jung-Hwan Lee
  • Patent number: 11925691
    Abstract: One aspect of the present invention provides a compound in which a functional group capable of binding to a globulin Fc region or a physiologically active polypeptide is introduced at one end of a non-peptidic polymer and a functional group capable of a click reaction is introduced at the other end; a polypeptide conjugate in which a physiologically active polypeptide binds to one end of the compound; a physiologically active polypeptide conjugate in which a physiologically active polypeptide and an immunoglobulin Fc region bind to both ends thereof by using the compound as a linker; and methods for preparing the same compound, polypeptide conjugate, and physiologically active polypeptide conjugate.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: March 12, 2024
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Su Yeon Park, Dae Jin Kim, Sung Youb Jung, Yong Gyu Jung, Hyun Sik Yun
  • Patent number: 11915782
    Abstract: An electronic device including a memory device with improved reliability is provided. The semiconductor device comprises a data pin configured to transmit a data signal, a command/address pin configured to transmit a command and an address, a command/address receiver connected to the command/address pin, and a computing unit connected to the command/address receiver, wherein the command/address receiver receives a first command and a first address from the outside through the command/address pin and generates a first instruction on the basis of the first command and the first address, and the computing unit receives the first instruction and performs computation based on the first instruction.
    Type: Grant
    Filed: August 20, 2021
    Date of Patent: February 27, 2024
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Chang Min Lee, Nam Hyung Kim, Dae Jeong Kim, Do Han Kim, Min Su Kim, Deok Ho Seo, Won Jae Shin, Yong Jun Yu, Il Gyu Jung, In Su Choi
  • Patent number: 11442057
    Abstract: The present invention relates to a method for screening an anticancer agent which inhibits the binding of AIMP2-DX2 and HSP70. In addition, the pharmaceutical composition for preventing or treating cancer comprising, as an active ingredient, an anticancer agent screened according to the method of the present invention inhibits the expression of HSP70 or inhibits the binding of HSP70 and AIMP2-DX2, thereby lowering the level of AIMP2-DX2 protein, and can effectively prevent the progression of cancer. As such, the pharmaceutical composition can be useful for developing a cancer treating agent.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: September 13, 2022
    Assignee: MEDICINAL BIOCONVERGENCE RESEARCH CENTER
    Inventors: Sunghoon Kim, Dae Gyu Kim, Semi Lim
  • Publication number: 20220204497
    Abstract: The present invention pertains to a novel compound having anticancer activity, and a method for producing same, and more specifically, to a novel compound that exhibits excellent anticancer activity by inhibiting the expression of AIMP2-DX2, and a method for producing same. The compound represented by chemical formula 1 according to the present invention is highly effective in inhibiting the expression of AIMP2-DX2, and thus can be very advantageously used for the development of agents for treating various diseases, in particular cancer, caused by AIMP2-DX2.
    Type: Application
    Filed: March 30, 2020
    Publication date: June 30, 2022
    Inventors: Sunghoon KIM, Dae Gyu KIM, Kyeong LEE, Minkyoung KIM
  • Patent number: 10545645
    Abstract: A method for realizing a user interface using a camera module and a mobile communication terminal for the same. If a user makes a predetermined motion in a state in which the camera module of the mobile communication terminal is activated, the mobile communication terminal performs a predetermined action according to the motion pattern by recognizing the user motion and patterning the motion. In this case, the action performed according to the motion pattern corresponds to mouse control in a mouse mode, game control in a game mode, and character input in a character input mode.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: January 28, 2020
    Assignee: Samsung Electronics Co., Ltd
    Inventors: Soon-Ok Kim, Dae-Gyu Kim, Yong-Soo Park
  • Publication number: 20190033295
    Abstract: The present invention relates to a method for screening an anticancer agent which inhibits the binding of AIMP2-DX2 and HSP70. In addition, the pharmaceutical composition for preventing or treating cancer comprising, as an active ingredient, an anticancer agent screened according to the method of the present invention inhibits the expression of HSP70 or inhibits the binding of HSP70 and AIMP2-DX2, thereby lowering the level of AIMP2-DX2 protein, and can effectively prevent the progression of cancer. As such, the pharmaceutical composition can be useful for developing a cancer treating agent.
    Type: Application
    Filed: September 7, 2018
    Publication date: January 31, 2019
    Inventors: Sunghoon Kim, Dae Gyu Kim, Semi Lim
  • Patent number: 10130611
    Abstract: This application relates to a novel benzo-heterocycle derivative and more particularly, it relates a composition for preventing and treating cancer or for inhibiting metastasis comprising benzo-heterocycle derivative or pharmaceutically acceptable salts thereof as an active ingredient. The present inventors confirmed that KRS has an effect on cancer metastasis by facilitating cancer (or tumor) cell migration through interaction with 67LR, and also found that a substance inhibiting the interaction between KRS and 67LR can prevent and treat cancer by inhibiting cancer cell metastasis. Accordingly, the composition of the present invention can inhibit cancer metastasis, and thus provide a novel means for prevention and treatment of cancer.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: November 20, 2018
    Assignee: MEDICINAL BIOCONVERGENCE RESEARCH CENTER
    Inventors: Sunghoon Kim, Jin Woo Choi, Jin Young Lee, Dae Gyu Kim, Gyoon Hee Han, Jee Sun Yang, Chul Ho Lee
  • Publication number: 20180088782
    Abstract: A method for realizing a user interface using a camera module and a mobile communication terminal for the same. If a user makes a predetermined motion in a state in which the camera module of the mobile communication terminal is activated, the mobile communication terminal performs a predetermined action according to the motion pattern by recognizing the user motion and patterning the motion. In this case, the action performed according to the motion pattern corresponds to mouse control in a mouse mode, game control in a game mode, and character input in a character input mode.
    Type: Application
    Filed: December 4, 2017
    Publication date: March 29, 2018
    Inventors: Soon-Ok KIM, Dae-Gyu KIM, Yong-Soo PARK
  • Patent number: 9836196
    Abstract: A method for realizing a user interface using a camera module and a mobile communication terminal for the same. If a user makes a predetermined motion in a state in which the camera module of the mobile communication terminal is activated, the mobile communication terminal performs a predetermined action according to the motion pattern by recognizing the user motion and patterning the motion. In this case, the action performed according to the motion pattern corresponds to mouse control in a mouse mode, game control in a game mode, and character input in a character input mode.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: December 5, 2017
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Soon-Ok Kim, Dae-Gyu Kim, Yong-Soo Park
  • Patent number: 9585537
    Abstract: The present invention relates to a dishwasher which comprises: a washer main body in which a washing basin is provided to form a space in which dishes are washed; multiple fixed jet nozzles which are fixed to the inner wall of the washing basin and jet water for washing toward the dishes at a fixed position; and a horizontally arranged cylindrical rotating rack rotatably disposed in the washing bath, wherein the inner space thereof is split into multiple dish mounting portions where the dishes can be mounted and the rotating rack rotates along the periphery of the multiple fixed jet nozzles.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: March 7, 2017
    Inventor: Dae Gyu Kim
  • Patent number: 9539236
    Abstract: Exemplary embodiments relate to a novel anticancer composition including a compound represented by chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient:
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: January 10, 2017
    Assignee: Medicinal Bioconvergence Research Center
    Inventors: Sunghoon Kim, Nam Hoon Kwon, Dae Gyu Kim
  • Patent number: 9544724
    Abstract: A location-based information service method for improving utilization of location-based information services and a mobile terminal for implementing the location-based information service method are provided. A method for providing an information service using a mobile terminal includes acquiring, at a mobile terminal, location information, determining an Internet Protocol (IP) address based on the location information, and receiving service information from a cyber space associated with a service provider that corresponds to the IP address.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: January 10, 2017
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Seung Min Choi, Sang Yoon Lee, Dae Gyu Kim, Jin Il Kim, Min Sook Park
  • Publication number: 20160152607
    Abstract: A maleic acid derivative represented by Chemical Formula 1 below or a pharmaceutically acceptable salt thereof: wherein, A is 5- to 7-membered phenyl having a substituent group, or heteroaryl or heterocycloalkyl containing at least one heteroatom selected from the group consisting of N, O, and S and having a substituent group, or 5- to 7-membered phenyl, heteroaryl, or heterocycloalkyl linked to C1-C5 straight- or branched-chain alkyl, wherein the substituent group is unsubstituted, halogen, OH, OR1, nitro, nitrile, NH2, NHR1, NR1R2 COOH, COOR1, CONH2, CONHR1, C1-C5 straight- or branched-chain alkyl, phenyl, heteroaryl, or 5- to 7-membered heterocycloalkyl, where R1 and R2 each are C1-C5 straight- or branched-chain alkyl, or phenyl or heteroaryl having a substituent group.
    Type: Application
    Filed: December 7, 2015
    Publication date: June 2, 2016
    Inventors: Sunghoon KIM, Nam Hoon Kwon, Dae Gyu Kim, Sunkyung Lee, Jong Hwan Song
  • Publication number: 20160146815
    Abstract: The present invention relates to a method for scanning a cancer metastasis inhibitor by analyzing the activity of lysyl-tRNA synthetase (KRS) in a cancer cell line cultured in a three-dimensional collagen gel environment, and to a method for monitoring the dissemination of cancer cells from aggregated cancer cells, and the epithelial-mesenchymal transition, migration, invasion, and metastasis of cancer cells. Specifically, it was verified that, in the case where a cell line or a spheroidically aggregated cell line, in which KRS has been regulated to be expressed or unexpressed, was constructed by using various colorectal cancer cells including HCT116 cell line and then cultured in a two-dimensional environment, the incomplete epithelial-to-mesenchymal transition phenotype (incomplete ECM phenotype) was induced in the cell line inhibiting KRS expression, and the inhibition of KRS expression inhibited cell-extracellular matrix (ECM) adhesion and cell-ECM signaling activity.
    Type: Application
    Filed: May 13, 2014
    Publication date: May 26, 2016
    Inventors: Jung Weon Lee, Sunghoon Kim, Seo-Hee Nam, Dae Gyu Kim
  • Patent number: 9206132
    Abstract: An aminopyridine derivative of Formula 1 and a method of preventing or treating cancer using the same. Formula 1: In Formula 1: X1 and X2 are each independently selected from the group consisting of carbon and nitrogen; R1 to R5 are each independently selected from the group consisting of a hydrogen, a straight, a branched, or cyclo alkyl of C1-C4, a halogen, and a hydroxyl; and R6 is a hydrogen or an alkyl of C1-C6.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: December 8, 2015
    Assignee: Medicinal Bioconvergence Research Center
    Inventors: Sunghoon Kim, Hee Sook Lee, Young Sun Oh, Dae Gyu Kim